10.23.26 -- Qualification And Validation Of Depyrogenation Tunnels And Autoclaves

Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

High-quality starting materials improve yield, reduce synthesis risk, and support reliable manufacturing across therapeutic development.

An optimized lyophilization cycle removes excess moisture during scale‑up by adjusting drying for larger equipment, improving stability, maintaining efficiency, and supporting clinical validation.

Strategic partnerships succeed through shared goals, transparency, cultural alignment, strong governance, and proactive communication, enabling faster development and greater resilience.

Assimilate how disciplined containment, proactive risk management, and collaboration accelerate oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

Uncover how end-to-end digital twins and Integrated Process Models are transforming manufacturing to enhance flexibility, accelerate time-to-market, and enable real-time decision-making.

Gain insight into how deterministic CCIT methods support sterility assurance, product stability, and patient safety for prefilled syringes, auto-injectors, and other combination products.

Engineering decisions in fill/finish directly shape product quality and sterility assurance. Examine how inert gas purging, plunger placement, dosing verification, and barrier systems interact across design.

Discover strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

Learn about the process conditions and protocols that were chosen as optimization targets and the resulting improvements to ADC production and purification that assessing these parameters provided.

In GMP operations, poor asset control quickly becomes a compliance risk. See how maintenance and calibration gaps lead to deviations and why demonstrable asset performance is essential.

Take a look at strategies to calibrate testing scope to risk, optimize execution workflows, and reduce operational burdens without compromising quality standards or safety compliance.

Upgrade sterility validation protocols by pairing quantitative enzyme indicators with biological indicators to reduce equipment downtime and confidently verify decontamination cycle efficacy. 

Navigating GLP-1 development in Europe? Gain insight into how stricter CMC, Annex 1, serialization, and supply chain requirements are influencing manufacturing strategies.

Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.

Review how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single partner.